dpp-4 inhibitor with glp-1 receptor agonist combination not recommended ada GLP-1-RA and inhibitors in the management of type 2 diabetes Complete pharmacology and pharmacotherapy of

Berberine, sometimes marketed as natures Ozempic, works through a completely different pathway

L.et al (1996)

Combination therapy with canagliflozin plus liraglutide exerts additive effect on weight loss, but not on HbA1c, in patients with type 2 diabetes

55 , e70000 (2025)

At the same time, they were used as a long-term treatment option for diabetes, and the presence of insurance policies enhanced their use

It appears safe to continue these medications before a procedure requiring anaesthesia or sedation, with minor precautions like abstaining from solid food for a day to minimize any potential risk of aspiration. Recent reports and studies suggest that taking GLP-1 medications is associated with slower digestion with a larger amount of food remaining in the stomach